Zobrazeno 1 - 10
of 207
pro vyhledávání: '"I. Wodinsky"'
Publikováno v:
JNCI: Journal of the National Cancer Institute. 59:405-408
Publikováno v:
Cancer research. 36(9 pt.1)
L-Asparagine synthetase appears in serum approximately 7 days after the s.c. implantation of 1 X 10(5) cells of Leukemia 5178Y/AR (resistant to L-asparaginase) and increases in activity as the neoplasm grows and metastasizes. The principal source of
Publikováno v:
European journal of cancer. 14(2)
Use of the chemosensitive tumor P388 lymphocytic leukemia has facilitated the demonstration of small but perhaps important schedule-dependent therapeutic effects with adriamycin (ADR) and cyclophosphamide (CY) combination therapy. Administration of A
Autor:
J A, Mabel, I, Wodinsky
Publikováno v:
Cancer. 51(4)
Mitomycin C (MMC) has been evaluated in combination with several antitumor agents. Full dose response curves were established for all drugs and drug combinations. Synergy was shown with MMC plus either cyclophosphamide (CYC) or methotrexate (MTX). In
Publikováno v:
Cancer treatment reports. 62(7)
The pharmacokinetics of 5-azacytidine (5-azaCR) and tetrahydrouridine (THU) were considered in evaluating the effect of THU on chemotherapy with 5-azaCR in L1210 leukemia mice. The administration of three different dose levels of THU and 5-azaCR ip i
Autor:
I, Wodinsky, J K, Swiniarski
Publikováno v:
Cancer chemotherapy reports. 59(5)
Experiments are described in which four transplantable rodent tumors (L1210 lymphoid leukemia, P388 lymphocytic leukemia, B16 melanoma, and Walker 256 carcinosarcoma) were used to investigate the antitumor activity of amygdalin MF. Amygdalin MF was g
Autor:
Richard M. Lambrecht, J. Shanij, T. Ido, K. Meaney, Alfred P. Wolf, C. Mantescu, R.D. Neirinckx, Harold L. Atkins, I. Wodinsky, T. Schlesinger, P.R. Bradley-Moore, R. MscGregor, Walter Wolf, V Casella, Peter M. Som, Joanna S. Fowler, D. Greenberg
Publikováno v:
International journal of nuclear medicine and biology. 5(1)
Extensive distribution studies of 18F-5-fluorouracil (18F-5-FU) in control and tumor-bearing mice (seven lines) and rats (eight lines) that have been shown or suspected to be responsive; to 5-FU treatment were investigated with 18F-5-FU. Studies were
Publikováno v:
Cancer research. 40(11)
The influence of the radiosensitizer misonidazole on the effectiveness of several alkylating agents and cis-platinum against advanced solid murine tumors was investigated. Tumor regrowth delay, frequency of tumor regressions, and animal life span wer
Publikováno v:
Cancer treatment reports. 60(4)
The antitumor activity of three of the most phosphoramide mustards, NSC-69947, NSC-72505, and NSC-72510, was compared with that of phosphoramide mustard (NSC-69945), the apparent active metabolite of cyclophosphamide (CP), against the L1210, P388, B1
Publikováno v:
Cancer research. 40(3)
1-beta-D-Arabinofuranosylcytosine (ara-C) was encapsulated in anionic multilamellar liposomes prepared with different lecithin: cholesterol (L:C) ratios. The chemotherapeutic activity of encapsulated ara-C was compared with comparable doses of ara-C